scispace - formally typeset
D

Dean D. Erdman

Researcher at Centers for Disease Control and Prevention

Publications -  208
Citations -  26613

Dean D. Erdman is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Respiratory tract infections & Human metapneumovirus. The author has an hindex of 72, co-authored 208 publications receiving 24423 citations. Previous affiliations of Dean D. Erdman include National Center for Immunization and Respiratory Diseases & University of Georgia.

Papers
More filters
Journal ArticleDOI

Human Metapneumovirus Infections in Young and Elderly Adults

TL;DR: It is concluded that hMPV infection occurs in adults of all ages and may account for a significant portion of persons hospitalized with respiratory infections during some years.
Journal ArticleDOI

Viral discovery and sequence recovery using DNA microarrays.

TL;DR: A DNA microarray-based platform for novel virus identification and characterization designed to detect a wide range of known viruses as well as novel members of existing viral families, which revealed the presence of a previously uncharacterized coronavirus in a viral isolate cultivated from a SARS patient.
Journal ArticleDOI

Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults

TL;DR: RSV should be considered in the differential diagnosis for adults hospitalized between November and April with community-acquired lower respiratory infection, with serologic evidence of RSV infection making RSV one of the four most common pathogens identified.
Journal ArticleDOI

Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.

TL;DR: A clear difference in the pulmonary inflammatory response to RSV between FI-RSV- and live- RSV-immunized mice suggests that this model can be used to evaluate the disease-enhancing potential of candidate RSV vaccines and better understand enhanced disease.